Kyron.bio
PrivateLast Round
Seed
May 28, 2025
Total Funding Raised
$7.46M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Kyron.bio operates in Healthcare & Life Sciences and is based in Paris. Its latest recorded funding round was a Seed round in May 2025.
Kyron.bio is a biotechnology company that develops precision glycoengineering technology to optimize the efficacy, safety, and scalability of therapeutic proteins and antibody drugs.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Kyron.bio Comparables
Compare Kyron.bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| GlycoDisplay ApS | 83% | |
| Augment Biologics | 83% | |
| NeuImmune, Inc. | 80% |
For institutional investors. Book with your work email.
Kyron.bio Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Kyron.bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Saras Capital | Seed |
| Verve Ventures | Seed |
| HCVC | Seed |
| Entrepreneurs First | Seed, Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2026
Monthly visitors increased 251% MoM, reaching 5.1K.
- Aug 18, 2026
Grew 50% QoQ, from 8 to 12 employees.
For institutional investors. Book with your work email.
Kyron.bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Kyron.bio's valuation, stock price, and market status.
Is Kyron.bio a public or private company?
Kyron.bio is a private company.
What is the current stock price of Kyron.bio?
Kyron.bio is a private company, so its shares have no public market price. Caplight tracks Kyron.bio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Kyron.bio worth (valuation)?
Valuation information for Kyron.bio is not publicly available.
Can I buy Kyron.bio stock?
Kyron.bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Kyron.bio's last funding round?
Kyron.bio's most recent funding round was Seed on May 28, 2025.
Who are the main investors in Kyron.bio?
Key investors in Kyron.bio include HCVC.
Will Kyron.bio IPO soon?
No public IPO plans have been announced for Kyron.bio.
How can I track Kyron.bio secondary market activity?
Caplight tracks bids, offers, and trades in Kyron.bio's shares on secondary markets.